Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Preventive Healthcare Services01:30

Preventive Healthcare Services

2.3K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.3K
Primary Healthcare Services01:30

Primary Healthcare Services

3.1K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolving attitudes towards cancer screening: a 2024 update of UK population views.

British journal of cancer·2026
Same author

The effect of different combinations of open invitations and timed appointments on breast screening attendance: service evaluation of invitation strategies in the NHS Breast Screening Programme.

British journal of cancer·2026
Same author

Optimising a behavioural intervention to support endocrine therapy adherence for women with breast cancer: protocol for the ROSETA optimisation factorial randomised controlled trial.

Trials·2026
Same author

Acceptability of Using Artificial Intelligence in the National Health Service Breast Screening Program: A Randomized Online Survey of Screening-Eligible Women in England.

Mayo Clinic proceedings. Digital health·2026
Same author

The Psychological Impact of Screen-Detected Cancer: A Systematic Review.

Psycho-oncology·2026
Same author

Experience of NHS diagnostic investigation following a multi-cancer early detection (MCED) screening test: qualitative interviews with NHS-Galleri trial participants who had a cancer signal detected.

EClinicalMedicine·2026

Related Experiment Video

Updated: May 3, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.5K

Does the HPV vaccination programme have implications for cervical screening programmes in the UK?

Helen Beer1, Sam Hibbitts2, Sinead Brophy3

  • 1Public Health Wales, Screening Division, Cervical Screening Wales, 18 Cathedral Road, Cardiff CF11 9LJ, Wales, UK.

Vaccine
|February 18, 2014
PubMed
Summary
This summary is machine-generated.

Women offered the human papillomavirus (HPV) vaccine in the UK catch-up program were less likely to attend cervical screening. HPV vaccination did not significantly impact abnormal screening results, but social deprivation affected both vaccination and screening uptake.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.9K

Related Experiment Videos

Last Updated: May 3, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

10.5K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

11.4K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.9K

Area of Science:

  • Public Health
  • Immunology
  • Gynecologic Oncology

Background:

  • The UK implemented a national HPV immunization program in 2008 for girls aged 12-13, with a catch-up program for older girls (up to 18) from 2009-2011.
  • Understanding the impact of HPV vaccination on cervical screening uptake and outcomes is crucial for national cervical screening program planning.

Purpose of the Study:

  • To analyze cervical screening uptake and clinical outcomes based on HPV vaccination status in women offered the vaccine through the catch-up program.
  • To identify factors influencing vaccination and screening attendance, particularly social deprivation.

Main Methods:

  • A record-linked database study analyzed data from 30,882 women in Wales who were invited for cervical screening between 2010 and 2012.
  • Cervical screening uptake, vaccination status, and cytology results were compared between vaccinated and unvaccinated women.
  • The impact of social deprivation on vaccination and screening uptake was assessed.

Main Results:

  • Of the cohort, 48.5% received HPV vaccination, and 45.9% attended cervical screening.
  • Unvaccinated women were significantly less likely to attend cervical screening (adjusted OR 0.58).
  • Abnormal cytology rates were similar between vaccinated (13.9%) and unvaccinated (16.7%) women who attended screening.
  • Women in highly deprived areas had lower vaccination (OR 0.48) and screening (OR 0.70) uptake.

Conclusions:

  • HPV vaccination through the catch-up program was associated with lower cervical screening attendance.
  • No significant difference in abnormal cytology was observed between vaccinated and unvaccinated women.
  • Social deprivation is a key factor associated with lower HPV vaccination and cervical screening uptake, highlighting the need for targeted strategies to reduce inequalities.